Iurii Rudyk
Iurii Rudyk is an expert in Cardiology at L.T. Malaya National Therapy Institute of the National Academy of Medical Sciences of Ukraine (Ukraine). Iurii Rudyk has authored 25 publications, the most recent in 2024, and is an investigator in 8 clinical trials. SLR score: 186 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2019 - 2026
L.T. Malaya National Therapy Institute of the National Academy of Medical Sciences of Ukraine -
Number : 25
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Cardio-ankle vascular index for predicting cardiovascular morbimortality and determinants for its progression in the prospective advanced approach to arterial stiffness (TRIPLE-A-Stiffness) study. PMID 38632024 — cardio ankle vascular index, mortality, biomedical research, ankle, risk factors, therapeutics, heart disease risk factors | EBioMedicine | 2024 | 20 |
| The associations of cytokines and gens polymorphisms of β-adrenoceptors in patients with heart failure and some thyroid pathology (literature review and own observations). PMID 38431814 — cytokines, genes, gtp-binding proteins, heart failure, pathology, thyroid gland, risk, receptors, adrenergic, alleles | Wiad Lek | 2024 | 0 |
| COURSE OF POST COVID-19 DISEASE IN HEART FAILURE PATIENTS WITH MODERATELY REDUCED LEFT VENTRICULAR EJECTION FRACTION. PMID 37419472 — infections, heart failure, history, quality of life, serum, coronavirus, furin, covid-19 | Georgian Med News | 2023 | 0 |
| Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. PMID 36876740 — stroke, myocardial infarction, incidence, cholesterol, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors | N Engl J Med Top journal | 2023 | 540 |
| Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. PMID 36342113 — diabetes mellitus, incidence, lipoproteins, non-alcoholic fatty liver disease, hypertriglyceridemia, cholesterol, therapeutics, lipoproteins, ldl, triglycerides, apolipoproteins, diabetes mellitus, type 2 | N Engl J Med Top journal | 2022 | 464 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map